等待开盘 10-16 09:30:00 美东时间
+0.170
+1.11%
今日重点评级关注:花旗:维持Arcus Biosciences"买入"评级,目标价从47美元升至54美元;HC Wainwright & Co.:上调Karyopharm Therapeutics评级至"买入",目标价15美元
10-14 09:56
4 analysts have shared their evaluations of Remitly Global (NASDAQ:RELY) during...
10-14 02:00
Goldman Sachs analyst Will Nance maintains Remitly Global (NASDAQ:RELY) with a Buy and lowers the price target from $26 to $21.
10-14 01:33
Democrats warn of health care crisis and criticize Republican and Trump for government shutdown, prioritizing politics over protecting Americans' coverage.
10-01 13:55
奇瑞汽车正式在港交所上市前夕,9月20日,威麟——奇瑞旗下皮卡品牌的首款车型威麟R08,投放到市场。 售价8.88万元-14.98万元,以此价格,尹同跃按捺不...
09-24 17:43
今日重点评级关注:Benchmark:维持Unicycive Therapeutics"投机性买入"评级,目标价从3美元升至21美元;Guggenheim:维持Amylyx Pharmaceuticals"买入"评级,目标价从17美元升至25美元
09-16 09:48
今日重点评级关注:D. Boral Capital:维持Veritone"买入"评级,目标价从6美元升至26美元;Guggenheim:维持Dianthus Therapeutics"买入"评级,目标价从92美元升至100美元
09-10 18:01
Wolfe Research analyst Darrin Peller upgrades Remitly Global (NASDAQ:RELY) from Peer Perform to Outperform and maintains the price target from $25 to $25.
09-09 23:20
Remitly Global launched Remitly One, a comprehensive financial membership enabling users to manage and grow money globally. The service includes Remitly Flex (interest-free funding), Remitly Wallet (with cash rewards), and Remitly Card (no foreign fees). Future features include multi-currency accounts, credit options, and additional perks. Available now for $9.99/month in the U.S., with plans to expand to other countries in 2026.
09-09 21:00
来源:环球网 8月29日,在成都国际车展上,奇瑞控股旗下全球皮卡智能生态品牌RELY威麟,携全场景皮卡智能技术平台——“威麟开天平台”,以及威麟P3X、威麟...
08-30 21:37